Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress

Biogen (NASDAQ: BIIB) December weekly option implied volatility is at 55, December is at 51; compared to its 52-week range of 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Biogen (BIIB) call put ratio 3.7 calls to 1 put with a focus on September calls
• AMD (AMD) call put ratio 1 call to 1.8 put with a focus on August 28 weekly 305 puts
• Norwegian Cruise Line (NCLH) call put ratio 1 call to 2.4 puts amid price movement